CAS: 1001350-96-4 - BMS-754807
Formula:C23subH24subFN9subO
- Synonyms:
- (2S)-1-[4-[(5-Cyclopropyl-1H-pyrazol-3-yl)amino]pyrrolo[2,1-f][1,2,4]triazin-2-yl]-N-(6-fluoro-3-pyridinyl)-2-methyl-2-pyrrolidinecarboxamide
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | BMS-754807 REF: IN-DA008TELCAS: 1001350-96-4 | % | To inquire | Mon 02 Dec 24 |
 | BMS 754807 REF: 4Z-B-221001CAS: 1001350-96-4 | - - - | To inquire | Tue 10 Dec 24 |
 | BMS 754807 REF: 3D-FB64960CAS: 1001350-96-4 | Min. 95% | 191.00 €~2,030.00 € | Wed 11 Dec 24 |
 | BMS-754807 REF: TM-T2349CAS: 1001350-96-4 | 98.86% | 49.00 €~755.00 € | Tue 07 Jan 25 |
Ref: IN-DA008TEL
| 1mg | 62.00 € | ||
| 5mg | 114.00 € | ||
| 10mg | 193.00 € | ||
| 25mg | 273.00 € | ||
| 50mg | 494.00 € | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 2 Dec 2024
Ref: 4Z-B-221001
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
BMS 754807
CAS:1001350-96-4
A reversible inhibitor of IGF-1R kinase and insulin receptor. Has anti-growth effects in mesenchymal, epithelial …
Formula:
C23H24FN9O
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
461.49 g/mol
Ref: 3D-FB64960
| 10mg | 191.00 € | ||
| 25mg | 381.00 € | ||
| 50mg | 542.00 € | ||
| 100mg | 948.00 € | ||
| 250mg | 2,030.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
BMS-754807
CAS:1001350-96-4
BMS-754807 is an oral IGF-1R/InsR inhibitor with potential anti-cancer properties.
Formula:
C23H24FN9O
Purity:
98.86%
Color and Shape:
Solid
Molecular weight:
461.49
Ref: TM-T2349
| 1mg | 49.00 € | ||
| 2mg | 69.00 € | ||
| 5mg | 94.00 € | ||
| 10mg | 163.00 € | ||
| 25mg | 321.00 € | ||
| 50mg | 525.00 € | ||
| 100mg | 755.00 € | ||
| 1mL*10mM (DMSO) | 116.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
